Breaking news in heart failure: ESC Guidelines 2016, non-steroidal mineralocorticoid receptor antagonist, and alternate site CRT pacing

被引：0
|
作者：
Luescher, Thomas F. [1 ]
机构：
[1] Zurich Heart House,Careum Campus,Moussonstr 4, CH-8091 Zurich, Switzerland
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷 / 27期
关键词：
CARDIOVASCULAR RISK; OUTCOMES; ASSOCIATION; EPLERENONE; FINERENONE;
D O I：
10.1093/eurheartj/ehw306
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2085 / 2087
页数：3
相关论文
共 45 条
  • [1] Non-steroidal mineralocorticoid receptor antagonists in heart failure
    Filippatos, Gerasimos
    Farmakis, Dimitrios
    NATURE REVIEWS CARDIOLOGY, 2023,
  • [2] Non-steroidal mineralocorticoid receptor antagonists in heart failure
    Filippatos, Gerasimos
    Farmakis, Dimitrios
    NATURE REVIEWS CARDIOLOGY, 2023, 20 (10) : 645 - 646
  • [3] The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction
    Ulrich Kintscher
    Frank Edelmann
    Cardiovascular Diabetology, 22
  • [4] The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction
    Kintscher, Ulrich
    Edelmann, Frank
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [5] SUPPRESSION OF MOUSE CRESCENTIC GLOMERULONEPHRITIS WITH A NON-STEROIDAL MINERALOCORTICOID RECEPTOR ANTAGONIST
    Tesch, G. H.
    Han, Y.
    Ma, F.
    Nikolic-Paterson, D. J.
    Kolkhof, P.
    NEPHROLOGY, 2015, 20 : 33 - 34
  • [6] Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction
    Lima-Posada, Ixchel
    Stephan, Yohan
    Soulie, Matthieu
    Palacios-Ramirez, Roberto
    Bonnard, Benjamin
    Nicol, Lionel
    Kolkhof, Peter
    Jaisser, Frederic
    Mulder, Paul
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [7] The non-steroidal mineralocorticoid receptor antagonist finerenone prevents structural cardiac remodeling
    Lavall, D.
    Jacobs, N.
    Mahfoud, F.
    Kolkhof, P.
    Boehm, M.
    Laufs, U.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3326 - 3326
  • [8] The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling
    Lavall, Daniel
    Jacobs, Nadine
    Mahfoud, Felix
    Kolkhof, Peter
    Boehm, Michael
    Laufs, Ulrich
    BIOCHEMICAL PHARMACOLOGY, 2019, 168 : 173 - 183
  • [9] The use of a novel non-steroidal mineralocorticoid receptor antagonist finerenone for the treatment of chronic heart failure A systematic review and meta-analysis
    Pei, Hui
    Wang, Wei
    Zhao, Di
    Wang, Lei
    Su, Guo-Hai
    Zhao, Zhuo
    MEDICINE, 2018, 97 (16)
  • [10] Pronounced cardiac protection by BAY 94-8862, a novel non-steroidal mineralocorticoid receptor antagonist in a preclinical rat model of heart failure
    Albrecht-Kuepper, B.
    Kretschmer, A.
    Kast, R.
    Baerfacker, L.
    Schaefer, S.
    Kolkhof, P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 7 - 7
12345